MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
2017 · Cell Death and Disease · 59 citations
https://doi.org/10.1038/cddis.2017.525
X
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
705
Citations
15
h-index
19
i10-index
Xin Yang is an academic researcher from University of Electronic Science and Technology of China. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related molecular mechanisms research & MicroRNA in disease regulation. The author has an h-index of 15, co-authored 51 publications.
ORCID: 0000-0002-3440-085XPapers by this author
worksMicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway
2020 · Biomedicine & Pharmacotherapy · 30 citations
https://doi.org/10.1016/j.biopha.2020.109994
Comparison of the diagnostic accuracy of enhanced-CT and double contrast-enhanced ultrasound for preoperative T-staging of gastric cancer: a meta-analysis
2025 · Cancer Imaging · 3 citations
https://doi.org/10.1186/s40644-025-00861-5
Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III–IVA esophageal squamous cell carcinoma post-surgery
2024 · Journal of Cardiothoracic Surgery · 2 citations
https://doi.org/10.1186/s13019-024-02500-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat